Discontinued — last reported Q1 '26
Bridion — Sales
Merck & Co. Bridion — Sales decreased by 52.8% to $472.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 46.5%, from $882.00M to $472.00M. Over 4 years (FY 2021 to FY 2025), Bridion — Sales shows an upward trend with a 4.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher sales indicate strong market demand and product performance, while declining sales may signal market saturation or competitive pressure.
Detailed definition
The total revenue generated from the sale of the specific product line during the reporting period. This metric reflects...
Peer comparison
Standard 'product revenue' or 'segment sales' metric used by all public companies to report performance of specific business units.
mrk_segment_bridion_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $774.00M | $738.00M | $872.00M | $789.00M | $853.00M | $846.00M | $881.00M | $973.00M | $1.00B | $848.00M | $859.00M | $880.00M | $910.00M | $840.00M | $898.00M | $882.00M | $922.00M | $878.00M | $999.00M | $472.00M |
| QoQ Change | — | -4.7% | +18.2% | -9.5% | +8.1% | -0.8% | +4.1% | +10.4% | +3.2% | -15.5% | +1.3% | +2.4% | +3.4% | -7.7% | +6.9% | -1.8% | +4.5% | -4.8% | +13.8% | -52.8% |
| YoY Change | — | — | — | — | +10.2% | +14.6% | +1.0% | +23.3% | +17.7% | +0.2% | -2.5% | -9.6% | -9.4% | -0.9% | +4.5% | +0.2% | +1.3% | +4.5% | +11.2% | -46.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s bridion — sales?
- Merck & Co. (MRK) reported bridion — sales of $472.00M in Q1 2026.
- How has Merck & Co.'s bridion — sales changed year-over-year?
- Merck & Co.'s bridion — sales decreased by 46.5% year-over-year, from $882.00M to $472.00M.
- What is the long-term trend for Merck & Co.'s bridion — sales?
- Over 4 years (2021 to 2025), Merck & Co.'s bridion — sales has grown at a 4.7% compound annual growth rate (CAGR), from $3.06B to $3.68B.
- What does bridion — sales mean?
- Total revenue earned from selling this specific product.